To further explore the potential pro-tumor role of Runx3 in AML, equal numbers of control (Vector) or Runx3 knockdown (Runx3 KD) murine AML cells were transplanted into syngeneic wild-type (WT) recipients (Figure 2A). Here, RUNX3 is linked to acute myeloid leukemia.